A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM - Trial 2022-001809-50
Access comprehensive clinical trial information for 2022-001809-50 through Pure Global AI's free database. This phase not specified trial is sponsored by Pfizer Inc. and is currently Ongoing. The study focuses on Heart failure.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2022-001809-50
Ongoing
Trial Details
EU Clinical Trials Register • 2022-001809-50
A PHASE 2, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, 4-ARM
Study Focus
Sponsor & Location
Pfizer Inc.
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Medical Conditions:
ICD-10 Classifications
Heart failure
Heart failure, unspecified
Congestive heart failure
Hypertensive heart disease with (congestive) heart failure
Left ventricular failure
Data Source
EU Clinical Trials Register
2022-001809-50
Non-Device Trial